X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (139) 139
Publication (26) 26
Book / eBook (10) 10
Newspaper Article (6) 6
Government Document (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (52) 52
female (49) 49
index medicus (48) 48
oncology (34) 34
middle aged (31) 31
adult (30) 30
breast cancer (30) 30
aged (25) 25
chemotherapy (22) 22
article (19) 19
breast neoplasms - drug therapy (16) 16
breast neoplasms - genetics (15) 15
male (15) 15
breast neoplasms - pathology (14) 14
cancer (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
abridged index medicus (11) 11
survival (10) 10
care and treatment (9) 9
cohort studies (9) 9
medicine & public health (9) 9
metastasis (9) 9
surgery (9) 9
trastuzumab (9) 9
treatment outcome (9) 9
aged, 80 and over (8) 8
clinical trials (8) 8
immunotherapy (8) 8
neoplasm metastasis (8) 8
open-label (8) 8
therapy (8) 8
breast neoplasms - metabolism (7) 7
lapatinib (7) 7
prognosis (7) 7
prospective studies (7) 7
research (7) 7
toxicity (7) 7
tumors (7) 7
cells (6) 6
expression (6) 6
magnetic resonance imaging (6) 6
management (6) 6
mutations (6) 6
neoadjuvant therapy (6) 6
neoplasm staging (6) 6
risk factors (6) 6
triple negative breast neoplasms - drug therapy (6) 6
tumor-infiltrating lymphocytes (6) 6
adolescent (5) 5
antibodies, monoclonal, humanized - administration & dosage (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
biomarkers, tumor (5) 5
cancer therapies (5) 5
child, preschool (5) 5
dna methylation (5) 5
erbb-2 protein (5) 5
genetics (5) 5
infant (5) 5
medicine, general & internal (5) 5
methylation (5) 5
multicenter (5) 5
mutation (5) 5
neoadjuvant chemotherapy (5) 5
original reports (5) 5
paclitaxel - administration & dosage (5) 5
patients (5) 5
pharmacology & pharmacy (5) 5
women (5) 5
young adult (5) 5
analysis (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
biopsy (4) 4
breast neoplasms - surgery (4) 4
cancer patients (4) 4
child (4) 4
children (4) 4
classification (4) 4
diagnosis (4) 4
genes (4) 4
genetics & heredity (4) 4
immunohistochemistry (4) 4
implementation (4) 4
infant, newborn (4) 4
logistic models (4) 4
mortality (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
patient outcomes (4) 4
phase-ii (4) 4
postoperative care/methods (4) 4
postoperative care/statistics and numerical data (4) 4
precision medicine (4) 4
predictive value of tests (4) 4
receptor, erbb-2 - analysis (4) 4
receptor, erbb-2 - genetics (4) 4
receptors, estrogen - analysis (4) 4
skin and connective tissue diseases (4) 4
solid tumors (4) 4
trial (4) 4
triple negative breast neoplasms - pathology (4) 4
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (7) 7
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Treatment and Research, ISSN 0927-3042, 2018, Volume 173, pp. 155 - 165
An effective antitumor immune response requires interaction between cells of the adaptive and innate immune system. Three key elements are required: generation... 
Immunotherapy | Breast cancer | Immune checkpoint inhibitors | B7-H1 Antigen - antagonists & inhibitors | Humans | Female | Programmed Cell Death 1 Receptor - antagonists & inhibitors | B7-H1 Antigen - analysis | Breast Neoplasms - drug therapy
Journal Article
Modern Pathology, ISSN 0893-3952, 02/2006, Volume 19, Issue 2, pp. 264 - 271
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 12/2017, Volume 9, Issue 4, pp. 227 - 235
Activating the immune system to eradicate breast cancer has emerged as a promising treatment strategy, and immune checkpoint inhibition has demonstrated... 
Medicine & Public Health | Immunotherapy | Oncology | Internal Medicine | Breast cancer | Immune checkpoint inhibitors | Surgical Oncology | Chemotherapy | Drug therapy | Cancer
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 1, pp. 23 - 34
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 1, pp. 11 - 22
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2008, Volume 14, Issue 24, pp. 7988 - 7999
Journal Article
Journal Article
2007, AD-a470 889.
Several groups have demonstrated that women with BRCA1 germline mutations are more likely to have breast cancers that are basal-like by gene expression... 
suppressors | toxicity | biology | genetics | mutations | genes | deoxyribonucleic acids | methylation | cells(biology) | breast cancer | neoplasms
Government Document
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4066 - 4076
Journal Article